Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If you are chatting with me sir. You are a dope. I am only asking for what a serious investor such as Bigger and Thermo have repeatedly asked for.
Ok. Maybe you need to do a bit more research to understand the agreement.
Sure, UCLA is running combination trials that cost us nothing. I hope they run many more. NWBO is the commercial producer of the product. So a university runs trials reaffirming the many uses of the vaccine that NWBO has all commercial rights.
A great lack of comprehension on your part.
“ Also I am pleased they reiterated their plans for further combination trials and trials in other cancer types.”
That is all I got out of this. I get more from thermo and Bigger. Bigger a year ago was saying look to combinations. Thermo saying they will talk more after approval.
Fine. They need to talk more and combinations with who and what. They are already spending money setting up for these studies. Time to talk every quarter. And talk money. Bigger sees exponential growth. It is a good story to tell because I believe it to be the truth.
Ok Dopey.
And the fact that so called “analyst” is the only analyst is the problem. Without proper guidance and quarterly calls you cannot get anyone worthwhile to follow the company.
I have held stocks attacked by your nemesis. It does not excuse the actions by the company. The guy attacks just about every small biotech because the odds for most are failure and he can claim he is an expert.
From what I understand based on past postings of the process you need MMA approval prior to NICE. Not submission.
You have to have MMA to get the NICE decision on pricing. But you have to think they would be talking about pricing.
A PR isn’t necessary if you communicate properly during the quarter. Below are some questions of a recent poster and they are valid. I have other questions of my own. This has nothing to do with someone or something spoofing or acting with malicious intent. You need quarterly calls with open Q&A from accredited analysts.
1. Marketing application(s)
(Preparation status, Target countries, Regulatory pathway(s), Target submission date(s)/acceptance date(s), Target RA decision date(s))
2. Manufacturing
(Current monthly DCVax-L capacity, 12-month target monthly DCVax-L capacity, CRL, Eden, Autolomous)
3. Specials
(Number treated (monthly, trailing 12 months; 12-month target), Revenue realized (monthly, trailing 12 months; 12-month target))
4. Uplisting
(Target exchange, Target date, Protocol/process/timing)
5. Cash
(C shares available/placed, Common shares available/placed, Institutional investors)
6. DCVax-L GBM
(Trial(s), PIP (Target start date, Target end date, Partner(s)), Combos (Target start date, Target end date, Partner(s)))
7. DCVax-L non-GBM cancers
(Trial(s), Partner(s), Combo(s), Basket(s), Agnostic marketing application(s))
8. DCVax-D
(Trial(s), Partner(s), Combo(s), Basket(s), Agnostic marketing application(s))
Wow. Sanity.
Better stuff here.
Last FDA regulation I saw posted here was you get the approval and in tandem with sales you run the studies for the indications you want to sell in.
Whatever you say. Just disagree.
Could be applying for tissue agnostic as well. All they can do is say ok for GBM but for all tissue it is a “NO” or a “YES” with combination studies.
How could it take even these people this long after DL if it was not for more? Just my take. The Italian paper indicated pretty much that path if only for GBM. Doubt any useful information will appear in the 10q.
If you got that information off of a quote server it is hardly ever correct.
The second graph of method A/B is pretty impressive. Pretty obvious why B is the one.
Please do not be one of those fools that includes the Planet as one of the Ps. They just worm their way into your life by redefining things.
We all know this. Unfortunately, there is zero coverage by any Wall Street big hitters. We all know whose fault it is. It is not marketing the product to talk about results at an investor conference and what the $ potential is in the market.
Yes - but the authors of the article bought 1000 shares each. If they buy another 1000 each the price will explode!
I agree Doc. But she still cheapened my investment. That is all I care about.
The guy predicting prices and changing them sometimes from hour to hour is an idiot.
A company like REGN survives and gets larger by teaming with Sanofi. Too great stories of partnerships resulting in buyouts. Direct would have been on the market by now with many indications and we would have 7 to 8 times less outstanding shares at full production. A partnership would also have stopped all the malfeasance by traders and given this company well needed discipline.
As far as I am concerned, the bad decisions have cut my final investment analysis by over 3 times. Now it is tough to say if a partner could bring as much but this crew is tired and I am so tired of them. I wish to see them not running the day to day.
Silence could also mean negotiations. They need someone with deep pockets.
Freeh gave Biden’s grandchild $100K as a gift for an introduction to someone in Romania by Hunter. I would say he has the inside track to the WH. Black may have been on the Burisma Board with Hunter but money talks.
Years ago when Woodford put up Freeh for the BOD, Linda just jammed a stick into Woodford’s eye and never looked back. At that time we lost all support of the markets. Really bad form just to save her multiple positions.
Black was the wrong guy. Needed someone with ties to the DOJ like Freeh. They didn’t need a spy.
“NWBO did not have the money to push Direct forward just to have it sitting at the gate like L. “
Whose fault is that Doc! Needed a partner years ago.
It takes 8 days to make the vaccine. So with shipping say 12 day turn around. Doubt using the helmet is worth the price or time frame.
I am not an expert but that is my take.
I just decided to look at the end of day action. Just saw your post. Biopsy? You need surgery and enough chunk of tumor to make L. Direct is more like putting a catheter into the tumor(s). Not sure what you are getting at.
There is another option.
And of the 3, two companies got bought and one got FDA approval. There is always stronger players that are in the know.
I expect a partnership or a BO with a share swap.
It does not excuse these people who have been horrible over the years. But I have owned 3 stocks that have gotten hammered prior to significant good news. So I have to stay the course on this downturn orchestrated by someone from the gap down around mid June.
Even if she turned it around, started executing for all cancer giving a 1000X bagger from here, I would be just as reluctant to invest with her again.
You’re the one. Sorry.
You clearly have not comprehended my posts since May 10. Also, your the one mostly posting what seems to be inferior competition.
How about today you have the last word and I will not respond.
You are smart guy but sometimes you go off the rails because of a strong dislike for the company. You provide me zero input why I should hate the science so we just disagree.
It is about the process best I can tell. Otherwise I do not have much of an answer for you. I also feel you cannot provide much beyond the question for me.
L in combination is doing it without chemotherapy and radiation. University medical centers do it for money. The company paired with them has to try and move something forward otherwise it doesn’t exist. There are so many failed tests but it doesn’t stop a company from trying.
For NWBO at a greater than 50% cure rate with combination it is pretty much a slam dunk. The fact DCVax is also the control group in these studies says positive things about the DCVax product as a stand alone treatment.
I know it pains you but I think NWBO is far ahead. The combination studies with the NWBO vaccine are showing greater than 50% cure rate.
That is a bit radical. A chamber in your abdomen. Then chemotherapy and radiation.